pharmaphorum

MARCH 14, 2022

Cambridge, UK-based Coalesce, first formed in 2009 primarily as a contract services business, changed direction in 2014 to develop its own, in-house inhaler technologies.

Generic Medicine 103

Generic Medicine Biosimilars 103

Quality Matters

NOVEMBER 27, 2023

Amy Cadwallader (ABC): Drug shortages have reached an all-time high since 2014, and USP, along with several others, has been calling for more efforts to coordinate pharmaceutical supply chain resilience and reliability activities among federal agencies and non-governmental stakeholders.

Generic Medicine 105

Generic Medicine Hospitals 105

Express Pharma

JULY 3, 2023

The Food and Drug Administration (FDA) approved an average of 43 drugs in 2014-18, compared to an average of 23 in the first decade of the century. India is known as the ‘Pharmacy of the World’, as the generic medicine supplier for over 200 countries, both developed and emerging markets. How poised are you to leverage them?

Biosimilars 74

Biosimilars Drug Development Generic Medicine Diabetes 74

Quality Matters

JUNE 26, 2023

Complex generics: Are global regulators addressing the needs? The development of generic versions of innovator medicines is a global public health need. EMA-FDA Parallel Scientific Advice: Optimizing Development of Medicines in the Global Age. Geneva: World Health Organization; 2014. WHO Drug Inf.

Dosage 52

Dosage Generic Medicine Labelling 52

Quality Matters

SEPTEMBER 15, 2023

For example, FDA established its Emerging Technology Program (ETP) in 2014 to facilitate emerging technologies like PCM and has already marked significant progress, Fisher said. Director, Science Staff, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research (CDER), FDA.

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing Communication 52

Express Pharma

SEPTEMBER 11, 2023

This move unburdened the private pharma companies allowing them to concentrate and strengthen their base, and they succeeded in gaining a national as well as international market presence as “global generic medicine manufacturers.” Prices of brands are paradoxically high Pharma contributes 43.2

Generic Medicine 69

Generic Medicine Diabetes Immunity Immunization 69

Pharmaceutical Technology

DECEMBER 19, 2022

Joy Polefrone, the executive director of the organization, says it aims to build a cluster of partners who are capable of manufacturing generic medicines. billion in equity since it started in 2014. The US Department of Commerce’s Economic Development Administration (EDA) awarded the organization $52.9 ” This $1.5

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Generic Medicine 69